Arrakis Therapeutics Alternatives & Competitors
12 companies similar to Arrakis Therapeutics — Arrakis is on a path to bring powerful new RNA-targeted small molecule (rSM) the...
Companies similar to Arrakis Therapeutics
Septerna
Bringing a new era of GPCR medicines to patients with its Native Complex Platform™.
South San Francisco, Unit...
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Kurashiki, Japan
FogPharma
Until everything is druggable.
Cambridge, United States
Rival Readout
Competing with Arrakis Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Totus Medicines
Making every disease treatable by making the total human genome druggable.
Emeryville, United States
ROME Therapeutics
Harnessing the power of the repeatome to develop a new class of therapies for cancer and a...
Boston, United States
Pharvaris
Pioneering science for patient choice
Zug, Switzerland
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Flare Therapeutics
Trailblazing the path to drugging transcription factors to discover precision medicines fo...
Cambridge, United States
Cytokinetics
Empowering Muscle Empowering Lives
South San Francisco, Unit...
About Arrakis Therapeutics
Arrakis Therapeutics is a pioneering player in the Biopharma and Biotechnology sector, headquartered in the United States. Founded in 2015, the company is on an ambitious mission to leverage RNA-targeted small molecule (rSM) therapies to revolutionize patient care. Their innovative approach adapts traditional drug disc...
RNA-targeted Small Molecule Development, Pipeline Management, Biotech Research and Development, Oral Medicines Development
Patients with Myotonic Dystrophy Type 1, Healthcare Providers, Biopharma Partners, Medical Researchers
RNA-targeted Therapies, Small-molecule Medicines, Drug Discovery, RNA Bioinformatics, RNA Structural Tools, Neurology, Oncology, Rare Genetic Diseases, RNA Biology, Pharmaceutical Innovation, Therapeutic Development, Medicinal Chemistry, Bioinformatics Integration
B2B, B2C, D2C
Licensing, Performance Based, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Arrakis Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Arrakis Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
